Marymount University
Arlington, Virginia, 22207, United States
NCT Number: NCT05544955
Protein ingestion timing is an important component for muscle accretion. The investigators hypothesized that protein ingestion timing could affect muscular adaptations and performance in resistance-trained men.
Looking for future studies?
Notify Me18 year–35 year
Male
Interventional
Not applicable
Arlington, Virginia, 22207, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This arm involved protein ingestion immediately prior to and immediately after resistance training for 12 weeks. Participants will consume 40 g of isolate whey protein at their recommended timing.
This arm involved protein ingestion 3 hours prior to and 3 hours after resistance training for 12 weeks. Participants will consume 40 g of isolate whey protein at their recommended timing.
Time frame: 12 weeks
Total Lean mass, fat mass, and estimated VAT (g) will be assessed using whole-body DXA
Time frame: 12 weeks
Using 1 repetition maximum
Time frame: 12 weeks
Using leg- and chest press exercises at 75% of the 1-RM
Time frame: 12 weeks
Using the vertical and broad jump tests
Time frame: 12 weeks
Using the pull-up test
Time frame: 12 weeks
Using Fasting blood samples
Time frame: 12 weeks
Urine samples will be collected using standard procedures
Time frame: 12 weeks
Using Fasting blood samples
Marymount University
Other
Comparison of Protein Ingestion Timing on Body Composition, Physical Performance, and Biochemical Markers in Resistance-trained Males
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05774444
Behavior, Hypertrophy
Glasgow, United Kingdom
View Trial DetailsNCT03572127
Hypertrophy, Pathological Conditions, Anatomical
Exeter, Devon, United Kingdom
View Trial DetailsNCT05576337
Hypertrophy, Pathological Conditions, Anatomical
Porto Alegre, Rio Grande do Sul, Brazil
View Trial DetailsNCT06121869
Behavior, Hypertrophy
Saint Charles, Missouri, United States
View Trial Details